Athira Pharma

-$0.67 (-3.45%) Today
$0.00 (0.00%) As of 8:06 PM UTC after-hours

Why Robinhood?

You can buy or sell Athira Pharma and other stocks, options, and ETFs commission-free!

About ATHA

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline include ATH-1017, ATH-1019/20, and ATH-1018.

CEO
Leen Kawas
Employees
22
Headquarters
Bothell, Washington
Founded
2011

ATHA Key Statistics

Market Cap
722.31M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
687.30K
High Today
$19.64
Low Today
$18.55
Open Price
$19.49
Volume
225.76K
52 Week High
$34.79
52 Week Low
$15.79

ATHA Earnings

-$1.12
-$0.75
-$0.37
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure